Mastodon

Peponen (Capsules) Instructions for Use

Marketing Authorization Holder

Teva Pharmaceutical Industries, Ltd. (Israel)

Manufactured By

Teva Pharmaceutical Works, Private Limited Company (Hungary)

ATC Code

G04CX (Other preparations for the treatment of benign prostatic hyperplasia)

Active Substance

Pumpkin seed (BP British Pharmacopoeia)

Dosage Form

Bottle OTC Icon Peponen Capsules 300 mg: 90 or 100 pcs.

Dosage Form, Packaging, and Composition

Capsules soft gelatin, reddish-brown in color.

1 caps.
Pumpkin seed oil 300 mg

10 pcs. – blisters (10) – cardboard packs.
10 pcs. – blisters (9) – cardboard packs.

Clinical-Pharmacological Group

Herbal preparation used for functional urinary disorders associated with benign prostatic hyperplasia

Pharmacotherapeutic Group

Herbal remedy for the treatment of prostate adenoma

Pharmacological Action

An agent of plant origin. It contains biologically active substances obtained from pumpkin (carotenoids, tocopherols, phospholipids, sterols, phosphatides, flavonoids, vitamins B1, B2, C, P, PP, F, saturated, unsaturated and polyunsaturated fatty acids – palmitic, stearic, oleic, linoleic, linolenic, arachidonic). It has antiulcer, hepatoprotective and choleretic effects. Reduces the proliferation of prostate cells. It has an anti-inflammatory effect.

Pumpkin seeds have anthelmintic activity against tapeworms (including beef tapeworm, pork tapeworm, dwarf tapeworm, broad tapeworm). It is believed that the component with anthelmintic action is contained mainly in the thin gray-green shell inside the pumpkin seed.

Indications

For oral administration: hepatitis, fatty liver dystrophy, cholecystocholangitis, biliary dyskinesia, gastritis, heartburn, gastric and duodenal ulcer, colitis, enterocolitis, hemorrhoids, atherosclerosis, prostatitis, benign prostatic hyperplasia, cervical erosion. Deworming and prevention of parasite carriage of various tapeworms.

For external and local use: herpes, dermatitis, diathesis, psoriasis, eczema, burns and burn disease, periodontitis.

ICD codes

ICD-10 code Indication
B00 Herpesviral [herpes simplex] infections
B83.9 Helminthiases, unspecified
I70 Atherosclerosis
K05 Gingivitis and periodontal diseases
K25 Gastric ulcer
K26 Duodenal ulcer
K29 Gastritis and duodenitis
K52.9 Noninfective gastroenteritis and colitis, unspecified
K64 Hemorrhoids and perianal venous thrombosis
K73 Chronic hepatitis, not elsewhere classified
K76.0 Fatty (change of) liver, not elsewhere classified
K81.0 Acute cholecystitis
K81.1 Chronic cholecystitis
K82.8 Other specified diseases of gallbladder and cystic duct (including dyskinesia)
K83.0 Cholangitis
L20.8 Other atopic dermatitis (neurodermatitis, eczema)
L30.0 Nummular eczema
L30.9 Dermatitis, unspecified
L40 Psoriasis
N40 Hyperplasia of prostate
N41 Inflammatory diseases of prostate
N86 Erosion and ectropion of cervix
R12 Heartburn
T30 Burns and corrosions of unspecified body region
ICD-11 code Indication
1F00.Z Infections due to herpes simplex virus, unspecified
1F9Z Helminthiases, unspecified
9A06.70 Atopic eczema of the eyelids
BD40.Z Atherosclerosis of peripheral arteries, unspecified
DA0B.Z Gingival diseases, unspecified
DA0C.Z Periodontal diseases, unspecified
DA0Z Diseases or disorders of the orofacial complex, unspecified
DA42.Z Gastritis, unspecified
DA51.Z Duodenitis, unspecified
DA60.Z Gastric ulcer, unspecified
DA63.Z Duodenal ulcer, unspecified
DA7Z Diseases of stomach or duodenum, unspecified
DA90.0 Syndromic diarrhea
DB6Z Hemorrhoids or perianal venous diseases, unspecified
DB92.0 Non-alcoholic fatty liver disease without steatohepatitis
DB92.Y Other specified non-alcoholic fatty liver disease
DB92.Z Non-alcoholic fatty liver disease, unspecified
DB97.2 Chronic hepatitis, not elsewhere classified
DC12.0Z Acute cholecystitis, unspecified
DC12.1 Chronic cholecystitis
DC13 Cholangitis
DC1Z Diseases of gallbladder and biliary tract, unspecified
DD94 Functional disorder of the gallbladder
DE2Z Diseases of the digestive system, unspecified
EA80.0 Infantile atopic eczema
EA80.1 Childhood atopic eczema
EA80.2 Adult atopic eczema
EA80.Z Atopic eczema, unspecified
EA82 Nummular dermatitis
EA85.20 Atopic hand eczema
EA85.2Z Hand dermatitis, unspecified
EA85.3 Foot dermatitis
EA89 Generalized eczematous dermatitis of unspecified type
EA8Z Dermatitis or eczema, unspecified
EA90.Z Psoriasis, unspecified
GA15.1 Erosion or ectropion of cervix
GA90 Hyperplasia of prostate
GA91.Z Inflammatory and other diseases of prostate, unspecified
MD95 Heartburn
NE11 Burn of unspecified body region

Dosage Regimen

The method of application and dosage regimen for a specific drug depend on its form of release and other factors. The optimal dosage regimen is determined by the doctor. It is necessary to strictly adhere to the compliance of the dosage form of a specific drug with the indications for use and dosage regimen.

Take orally with a sufficient amount of water.

For benign prostatic hyperplasia and prostatitis, take 300 mg three times daily.

For gastritis, gastric ulcer, duodenal ulcer, and heartburn, take 300 mg two to three times daily.

For hepatitis, fatty liver dystrophy, cholecystocholangitis, and biliary dyskinesia, take 300 mg three times daily.

For colitis and enterocolitis, take 300 mg twice daily.

For hemorrhoids, take 300 mg twice daily for a minimum of two weeks.

For atherosclerosis, take 300 mg three times daily for a prolonged duration.

For cervical erosion, take 300 mg twice daily.

For deworming of tapeworms, take a single dose of 5 grams to 10 grams for adults, or 150 mg/kg to 200 mg/kg for children, on an empty stomach.

For external use in herpes, dermatitis, psoriasis, eczema, and burns, apply the oil contents of the capsule topically to the affected area two to three times daily.

For periodontitis, apply the oil topically to the gums.

The duration of treatment is determined by the physician based on the clinical indication and patient response.

Adverse Reactions

When taken orally, mild belching is possible, rarely – diarrhea.

Contraindications

Not established.

Pediatric Use

Use is possible according to the dosage regimen.

Special Precautions

Can be used as monotherapy and as part of combination therapy.

Storage Conditions

Store at 2°C (36°F) to 25°C (77°F). Keep in original packaging, protected from light. Keep out of reach of children.

Dispensing Status

Over-the-Counter

Important Safety Information

This information is for educational purposes only and does not replace professional medical advice. Always consult your doctor before use. Dosage and side effects may vary. Use only as prescribed.

Medical Disclaimer

TABLE OF CONTENTS